FIELD: experimental medicine, oncology, dermatooncology.
SUBSTANCE: one should apply chemical carcinogen onto shaven part of rat's skin - 0.1%-7,12-dimethylbenz(a)anthracene (DMBA) as drops at the volume of about 35-49 mcl at 48-72-h-long interval between applications for 10-12 mo. This provides availability of rare basalioma's type as metatypical cancer in 99% rats at the terms of 42-48 wk.
EFFECT: higher efficiency.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSIS METHOD FOR DETERMINING SQUAMOUS CELL SKIN CARCINOMA AND KERATOACANTHOMA CASES | 2004 |
|
RU2279089C1 |
| METHOD OF FLUORESCENT DIAGNOSTICS OF BASAL CELL SKIN CANCER | 2008 |
|
RU2387376C1 |
| METHOD FOR PROGNOSTICATION OF DEVELOPMENT OF METACHRONNIC CARCINOMA OF SKIN | 2002 |
|
RU2241232C2 |
| METHOD FOR TREATING BASALIOMAS | 2002 |
|
RU2229306C1 |
| MEDICINAL AGENT FOR CANCER PREVENTION | 2006 |
|
RU2328294C1 |
| METHOD OF OBTAINING LUNG TUMPOURS IN EXPERIMENT | 2011 |
|
RU2475864C1 |
| METHOD OF SUPERFICIAL SKIN BASALIOMA THERAPY SELECTION | 2007 |
|
RU2327168C1 |
| METHOD FOR DETERMINING THE BOUNDARIES OF FULL-THICKNESS EYELID RESECTION IN MALIGNANT GROWTHS OF EPITHELIAL GENESIS | 2018 |
|
RU2707265C1 |
| METHOD FOR TREATING THE CASES OF MALIGNANT SKIN TUMORS | 2005 |
|
RU2300403C1 |
| AGENT FOR CANCER PROPHYLAXIS | 2005 |
|
RU2290178C1 |
